Loading news article.

FilingSEC EDGAR8-K

Standard BioTools Enters Agreement to Sell Microfluidics Business

Oct 5, 2026, 16:16 ET · SEC accepted

StageDefinitive Agreement

Filing content

Standard BioTools entered into a definitive agreement to sell its Microfluidics business to ARCHIMED, with the transaction expected to close in approximately 30 days.

AI summary of the filing. Please also check the source.

Related companies

STANDARD BIOTOOLS INC.LABView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…